Clinical Trials · NCT05005741
The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Second Xiangya Hospital of Central South University
- Enrollment
- 120
- Start date
- May 2021
- Locations
- 4 sites, China
- Primary endpoint
- haemoglobin A1c(HbA1c)